Immunohistochemistry was used to evaluate the expression of TPM3P9 in 385 ccRCC patients (Fig. 2k and Supplementary Table 1), showing higher expression of TPM3P9 in ccRCC tissues. The gene discussed is TPM3P9; the disease is nonpapillary renal cell carcinoma.